PT-141, also known as bremelanotide , is an FDA-approved treatment of hypoactive sexual desire disorder (HSDD) in women [1]
Bioglutide NA-931 capsules stand out as a groundbreaking therapeutic agent, representing the first-in-class quadruple receptor agonist that simultaneously targets four key metabolic pathways: Insulin-like Growth Factor 1 (IGF-1), Glucagon-like Peptide-1 (GLP-1), Glucose-dependent Insulinotropic Polypeptide (GIP), and Glucagon
BPC-157 is a synthetic peptide derived from a naturally occurring protein found in the gastric system
These high costs can limit which patients have access to drugs needed to treat type 2 diabetes or manage obesity
A targeted Glutathione and Green Tea jelly sheet mask that helps fade the look of dark spots, dullness, and uneven tone for clearer, more luminous skin
While minor swelling and bruising are expected, a professional should check for anything unusual